Lipe & Dalton’s Clorox CLX Stock Holding History

Lipe & Dalton’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$565K	Buy	+5,925	New	+$569K	0.26%	55
2020 Q2	–	Sell	-100	Closed	-$17K	–	98
2020 Q1	$17K	Buy	+100	New	+$16.5K	0.01%	93

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Lipe & Dalton's CLX Position: Q2 2026 in Review

Lipe & Dalton opened a new position in Clorox (CLX) in Q2 2026: 5,925 shares worth $565K. The stake represents 0.26% of the portfolio and ranks #55 among its holdings. This is a return to the name: Lipe & Dalton previously reported a position in CLX as recently as Q1 2020.

Lipe & Dalton first reported a position in CLX in Q1 2020 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Lipe & Dalton held 5,925 shares of Clorox worth $565K as of Q2 2026.
Clorox was a new Lipe & Dalton position in Q2 2026.
Clorox made up 0.26% of Lipe & Dalton's portfolio in Q2 2026, its #55 holding.
Lipe & Dalton first reported a position in Clorox in Q1 2020 and has held it in 2 quarters since.
1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.